Source comparison
The Mechanistic Truth About CJC-1295 No DAC vs IGF-1 LR3 Which Better Comparison
Here's the honest answer: there is no universal 'better' peptide between CJC-1295 no DAC and IGF-1 LR3 because they operate at entirely different points in the growth hormone-IGF-1 axis. Treating them as interchangeable alternatives is a fundamental misunderst
This comparison does not assign a generated winner or score.
- Here's the honest answer: there is no universal 'better' peptide between CJC-1295 no DAC and IGF-1 LR3 because they operate at entirely different points in the growth hormone-IGF-1 axis. Treating them as interchangeable alternatives is a fundamental misunderstanding of endocrinology. CJC-1295 no DAC amplifies your existing physiological machinery. It makes the pituitary release more growth hormone, which then drives downstream hepatic IGF-1 production and all the systemic effects that entails. IGF-1 LR3 bypasses that entire cascade and delivers the endpoint signal directly to tissue receptors, independent of whether your hypothalamus, pituitary, or liver are functioning normally. If your experimental question involves neuroendocrine regulation, feedback loops, or circadian GH dynamics, CJC-1295 no DAC is the only appropriate choice. If your question is about direct IGF-1 receptor activation at target tissues without confounding variables from upstream hormonal changes, IGF-1 LR3 is cor